This RFP is closed.

Conquer Cancer^®, the ASCO Foundation, in collaboration with Pfizer Global Medical Grants, has announced the recipients of grants totaling $900,000 to support studies focused on identifying disparities in delivery of care and treatment outcomes for patients of color with metastatic breast cancer (mBC) across the United States.  These grants are part of the Pfizer Global Medical Grants’ program “Equitable Care of Metastatic Breast Cancer (mBC) Patients: A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color”, which aims to promote and advance scientific knowledge concerning equitable care of patients with mBC by employing data-driven frameworks to define and address inequities in the delivery of patient care and outcomes. 

The grant recipients are:

Maysa Abu-Khalaf, MD

Thomas Jefferson University    

The impact of social determinants of health on cancer care delivery and outcomes of metastatic breast cancer patients 

Julie Bradley, MD

University of Florida    

Unveiling Inequities in Palliative and Supportive Care for Metastatic Breast Cancer Patients in the State of Florida

Carolyn Brown, PhD

The University of Texas at Austin

Assessing Equity of Care Across Metastatic Breast Cancer Treatment Junctures: A Data-Driven Vulnerability Cluster Approach

Generosa Grana, MD

MD Anderson Cancer Center at Cooper

Assessment of Equitable Care for Black and Women of Color with mBC

Katherine Reeder-Hayes, MD

University of North Carolina Lineberger Comprehensive Cancer Center    

Impact of Social Determinants on Treatment Access and Outcomes of Metastatic Breast Cancer Among Black Women

Shoshana Rosenberg, ScD, MPH    

Weill Cornell Medicine    

Identifying unmet needs and barriers to receipt of psychosocial care in men and women with metastatic breast cancer from diverse racial and ethnic backgrounds treated in an urban hospital network

In December 2022, Conquer Cancer and Pfizer brought these six investigators together for an Investigator Exchange meeting where they shared the findings and lessons learned from their analyses of inequities within their health-care systems, and engaged in a productive discussion about solutions needed to achieve equity and improve outcomes for underserved mBC patients.

EveryGrant^®

This grant is administered in collaboration with EveryGrant^®, Conquer Cancer, the ASCO Foundation’s, end-to-end, white label solution. EveryGrant^®  helps organizations develop and deliver grants programs that attract the brightest researchers and make a difference for people with cancer everywhere.